Status:

COMPLETED

HEMI-STIM. tDCS and Intensive Therapies

Lead Sponsor:

University of Castilla-La Mancha

Conditions:

Infantile Hemiplegia

Eligibility:

All Genders

4-8 years

Phase:

NA

Brief Summary

Application of Transcranial Direct Current or placebo combined with Constraint Induced Movement Therapy (CIMT) and bimanual intensive therapy (BIT) in infantile hemiplegia (4-8 years). Before, after t...

Detailed Description

Objectives: To determine the efficacy of the combined application of transcranial direct current (tDCS) with a restraint-induced movement therapy program and bimanual therapy on quality of life, quali...

Eligibility Criteria

Inclusion

  • Children between 4 and 8 years old, with a diagnosis of congenital infantile hemiplegia, with a score between levels I and III of the manual ability classification system (MACS) and a level I-III of the gross motor function classification system will be included (GMFCS). In addition, children must have a preserved cognitive ability to understand the execution of structured activities

Exclusion

  • Having previously been treated with tDCS; Having been infiltrated with botulinum toxin 2 months prior to the intervention; Surgery of the upper limb the 6 months prior to the intervention; Pharmacologically uncontrolled epilepsy or having suffered epileptic seizures in the two years prior to the study (according to international recommendations for tDCS in children, Gillick et al., 2018); Contraindications of tDCS according to international recommendations. In addition, a withdrawal criterion will be non-attendance for more than 20% of the hours of the program.

Key Trial Info

Start Date :

October 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2022

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT05226910

Start Date

October 1 2021

End Date

October 1 2022

Last Update

January 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Castilla-La Mancha

Toledo, Spain, 45071

HEMI-STIM. tDCS and Intensive Therapies | DecenTrialz